Pascal Bamford Akoya Biosciences, Inc. (AKYA) insider trading activity

AKYA Quotes by TradingView

Pascal Bamford is Chief Clinical Officer of Akoya Biosciences, Inc.. Currently has a direct ownership of 206,408 shares of AKYA, which is worth approximately $324,060. The most recent transaction as insider was on Mar 01, 2025, when has been sold 3,850 shares (Common Stock) at a price of $1.63 per share, resulting in proceeds of $6,275. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 206K
1.83% 3M change
n/a 12M change
Total Value Held $324,060

PASCAL BAMFORD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 01 2025
SELL
Payment of exercise price or tax liability
$6,275 $1.63 p/Share
3,850 Reduced 1.83%
206,408 Common Stock
Nov 19 2024
BUY
Grant, award, or other acquisition
-
87,500 Added 29.39%
210,258 Common Stock
Aug 29 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 24.58%
122,758 Common Stock
PB

Pascal Bamford

Chief Clinical Officer
Marlborough, MA

Track Institutional and Insider Activities on AKYA

Follow Akoya Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKYA shares.

Notify only if

Insider Trading

Get notified when an Akoya Biosciences, Inc. insider buys or sells AKYA shares.

Notify only if

News

Receive news related to Akoya Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKYA